Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02582307Phase 3Completed
A Phase 3 trial of hyoscine butylbromide in abdominal pain. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02582307.